Using Angiotensin-Converting Enzyme Inhibitors or Beta-Blockers to Preclude Trastuzumab and Anthracycline-Induced Cardiotoxicity in Breast Cancer Patients

Prof. RichardNASSER MOHAMMED N ALQAHTANI2022-06-012022-06-0130546https://drepo.sdl.edu.sa/handle/20.500.14154/57454Using Angiotensin-Converting Enzyme Inhibitors or Beta-Blockers to Preclude Trastuzumab and Anthracycline-Induced Cardiotoxicity in Breast Cancer PatientsThesis